ChemMedChem

Wiley

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

ChemMedChem is a journal published by Wiley in Germany. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,760 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
1860-7179 · 1860-7187
Country
Germany
Access
Not open access / not declared
Declared publication charge
3,760 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2006-01-01
  • PUBMED · 2010-02-01
Indexing
MEDLINE · PUBMED
APC
3,760 USD
Declared review time (DOAJ)
—
Actual review time (measured)
110 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

6621

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

120

i10-index

3135

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
86%
ORCID iDs in current deposits
90%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
101259013
Society affiliations
Chemistry Europe
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Synthesis and biological activity
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Synthesis and Characterization of Heterocyclic Compounds
  • Chemical Synthesis and Analysis
  • Click Chemistry and Applications
  • Click Chemistry and Applications
Show all subjects (75)
  • Chemical Synthesis and Analysis
  • Chemical Synthesis and Analysis
  • Synthesis and biological activity
  • Synthesis and biological activity
  • Metal complexes synthesis and properties
  • Receptor Mechanisms and Signaling
  • Synthesis and Biological Evaluation
  • Synthesis and Biological Evaluation
  • HIV/AIDS drug development and treatment
  • HIV/AIDS drug development and treatment
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Nanoparticle-Based Drug Delivery
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • Cholinesterase and Neurodegenerative Diseases
  • Enzyme function and inhibition
  • Synthesis and Biological Evaluation
  • Protease and Inhibitor Mechanisms
  • Nanoplatforms for cancer theranostics
  • Metal complexes synthesis and properties
  • Biochemical and Molecular Research
  • Biochemical and Molecular Research
  • Metal complexes synthesis and properties
  • Carbohydrate Chemistry and Synthesis
  • History and advancements in chemistry
  • History and advancements in chemistry
  • Nanoplatforms for cancer theranostics
  • Protein Degradation and Inhibitors
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • RNA Interference and Gene Delivery
  • Nanoplatforms for cancer theranostics
  • Radiopharmaceutical Chemistry and Applications
  • RNA Interference and Gene Delivery
  • Alzheimer's disease research and treatments
  • Protein Degradation and Inhibitors
  • Malaria Research and Control
  • HIV/AIDS drug development and treatment
  • Protein Degradation and Inhibitors
  • Click Chemistry and Applications
  • DNA and Nucleic Acid Chemistry
  • Microbial Natural Products and Biosynthesis
  • Protein Kinase Regulation and GTPase Signaling
  • Histone Deacetylase Inhibitors Research
  • Histone Deacetylase Inhibitors Research
  • Antimicrobial agents and applications
  • Monoclonal and Polyclonal Antibodies Research
  • Microbial Natural Products and Biosynthesis
  • Cholinesterase and Neurodegenerative Diseases
  • Monoclonal and Polyclonal Antibodies Research
  • Cholinesterase and Neurodegenerative Diseases
  • Microbial Natural Products and Biosynthesis
  • Carbohydrate Chemistry and Synthesis
  • Carbohydrate Chemistry and Synthesis
  • Protein Structure and Dynamics
  • HIV Research and Treatment
  • HIV Research and Treatment
  • Histone Deacetylase Inhibitors Research
  • Pharmacological Receptor Mechanisms and Effects
  • Pharmacological Receptor Mechanisms and Effects
  • DNA and Nucleic Acid Chemistry
  • DNA and Nucleic Acid Chemistry
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Phenothiazines and Benzothiazines Synthesis and Activities

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: